BioSpace News Archive

According to the report, the global medical talent management IT market was valued at US$ 991.8 Mn in 2019 and is projected to expand at a CAGR of ~10% from 2020 to 2030.

Transparency Market Research has published a new report titled, ‘Cardiac Pacemakers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global customized procedure trays market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a high CAGR during the forecast period.

Cathepsin B is an important mediator of inflammation and programmed cell death in individual cells. It has a role in inducing cell dissolution and recycling of cellular organelles.

Study Meets Primary Endpoint, Confirming the ADC [Vic-]Trastuzumab Duocarmazine is Superior to Physician’s Choice in Delaying Disease Progression

ONK Therapeutics Ltd, an innovative natural killer cell therapy company, announced that it has been awarded an Innovation Partnership Programme grant by Enterprise Ireland to fund collaborative research at Trinity College Dublin, Ireland, led by Dr. David Finlay to optimize the metabolism and engineering of NK cells for improved cancer therapies.

Pascal Biosciences Inc., has been awarded a grant of US$343,750 from the National Cancer Institute of the US National Institutes of Health.

bioSyntagma®, Inc unveiled the world’s first high-plex multi-omic spatial workflow designed for clinical samples and diagnostic applications.

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, announced that it is set to join the Russell 2000® and Russell 3000® Indexes at the conclusion of the Russell indexes annual reconstitution, effective after the US markets open on June 28, 2021.

Madrigal Pharmaceuticals, Inc, a clinical- stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need such as non-alcoholic steatohepatitis, announced its management team will participate in two upcoming virtual investor conferences